Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Inv. presentation
Quarterly results
Appointed director
Cibus, Inc. (CLXT) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 8-K Quarterly results
Docs: "Cibus Reports Second Quarter 2023 Financial Results and Provides Business Update"
06/29/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934",
"Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934"
06/01/2023 8-K Appointed a new director
Docs: "Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Calyxt, Inc.",
"Second Amended and Restated Certificate of Incorporation of Cibus, Inc.",
"Amended and Restated Bylaws of Cibus, Inc.",
"Registration Rights Agreement, by and among Cibus, Inc. and each of the persons identified on the Schedule of Investors attached thereto",
"Exchange Agreement, by and among Cibus, Inc., Cibus Global, LLC and each of the other persons identified on the signature pages thereto",
"Tax Receivable Agreement, by and among Cibus, Inc., Rory Riggs and each of the other persons identified on the signature pages thereto",
"Cover Page Interactive Data File (embedded within the Inline XBRL document)",
"Form of Indemnification Agreement for Directors and Officers of Cibus, Inc",
"First Amendment to the License Agreement, by and between Cellectis S.A. and Calyxt, Inc",
"Cibus, Inc. 2017 Omnibus Incentive Plan (As Amended)"
05/25/2023 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ...
05/19/2023 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits  Interac...
Docs: "Calyxt Announces Stockholder Approval of Merger With Cibus"
05/17/2023 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Departure ...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Second Amendment to the Executive Severance Plan",
"Annual Incentive Payment Criteria - In Respect of Fiscal Year 2023",
"PERFORMANCE STOCK UNIT AGREEMENT"
05/11/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Investor Presentation (May 2023)"
05/09/2023 8-K Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION"
05/05/2023 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Submission...
05/01/2023 8-K Quarterly results
Docs: "Calyxt Reports First Quarter 2023 Financial Results and Provides Corporate Update"
04/24/2023 8-K Quarterly results
04/21/2023 8-K Quarterly results
04/18/2023 8-K Quarterly results
04/14/2023 8-K Quarterly results
04/04/2023 8-K Regulation FD Disclosure, Financial Statements and Exhibits  Interactive Data
Docs: "Alternative Investor Presentation (April 2023)",
"Alternative Investor Presentation (April 2023)"
03/28/2023 8-K Quarterly results
03/16/2023 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant ...
03/02/2023 8-K Quarterly results
Docs: "Calyxt Reports Fourth Quarter 2022 Financial Results and Provides Corporate Update"
01/17/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Agreement and Plan of Merger, by and among Calyxt, Inc., Calypso Merger Subsidiary, LLC, Cibus Global, LLC and the other parties thereto",
"Amendment to Calyxt’s 2021 Executive Severance Plan",
"Calyxt and Cibus Announce Definitive Merger Agreement to Create Industry-Leading Precision Gene Editing and Trait Licensing Company",
"Social Media Posts posted by Cibus Global, LLC on January 17, 2023",
"Social Media Posts posted by Calyxt, Inc. on January 17, 2023"
11/17/2022 8-K Quarterly results
11/03/2022 8-K Quarterly results
10/06/2022 8-K Quarterly results
10/03/2022 8-K Quarterly results
09/22/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Calyxt, Inc. Exploring Strategic Alternatives"
08/04/2022 8-K Quarterly results
06/02/2022 8-K Quarterly results
05/20/2022 8-K Quarterly results
05/05/2022 8-K Quarterly results
03/28/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Form of Performance Stock Unit Agreement"
03/03/2022 8-K Quarterly results
02/23/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION",
"Underwriting Agreement, by and between Calyxt, Inc. and Canaccord Genuity LLC",
"Form of Pre-Funded Warrant",
"Form of Common Warrant",
"Opinion of Jones Day"
02/18/2022 8-K Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Updated Business Disclosure",
"Updated Risk Factor Disclosure"
11/04/2021 8-K Quarterly results
Docs: "Three Months Ended September 30, Nine Months Ended September 30, In Thousands 2021 2020 2021 2020 Gross profit $ $ $ $ Gross profit percentage % % % % Non-GAAP adjustments: Commodity derivative impact, net 1,107 1,107 Net realizable value adjustments to inventories 2,000 Adjusted gross profit $ $ $ $ Adjusted gross profit percentage % % % % 8 The Company presents adjusted net loss, a non-GAAP measure, and defines it as net loss including adjustments necessary to present the underlying gross profit of its soybean product line, including unrealized gains and losses associated with commodity derivatives entered into to hedge the change in value of fixed price grain inventories and fixed price forward purchase contracts that should be recognized in the future when the underlying inventory is ..."
10/05/2021 8-K Asset disposition
Docs: "Calyxt Announces New Strategic Direction to Provide Sustainable, Plant-Based Synthetic Biology Solutions to Expanded Group of End Markets and Diversified Base of Customers -Proprietary PlantSpringTM technology platform expanded and achieves rapid development of plant-based biomolecules- -PlantSpring leverages artificial intelligence and machine learning- -First pilot BioFactory™ manufacturing facility is being developed to work in concert with PlantSpring for producing plant biomolecules at scale and sustainably- -Continues current technology licensing and product development activities as synergistic components of the expanded business model- -Hosts conference call and webcast today at 4:30 p.m. ET- Roseville, MN – Tuesday, October 5, 2021 –"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy